Zobrazeno 1 - 10
of 18
pro vyhledávání: ''
Autor:
Satoshi Yuki, Ayana Endo, Taichi Murai, Shuji Nishikawa, Ayane Oba, Takahiko Kudo, Kazufumi Itaya, Yuji Ono, Yuta Koike, Tetsuhito Muranaka, Michio Nakamura, Yoshito Komatsu, Takayuki Sone, Atsushi Ishiguro, Masataka Yagisawa, Atsushi Nagasaka, Hiraku Fukushima, Kota Ono, Chika Matsuda, Yoko Tsukuda
Publikováno v:
The Oncologist
This study is an evaluation of the effect of gastrointestinal cancer chemotherapy with short‐term periodic steroid premedication on bone metabolism. Primary endpoints were changes in bone mineral densities and metabolic bone turnover 16 weeks after
Autor:
Ignacio Matos, Carlos F. Lopez, Daniel Castellano, Rocio Garcia-Carbonero, Ramon Salazar, Ana Custodio, Alexandre Teulé, Oriol Casanovas, Emma Dotor, Jorge Barriuso, Jose Luis Manzano, Vicente Alonso, Jaume Capdevila
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Background Antitumor activity of the combination of somatostatin analogues (SSAs) and the mammalian target of rapamycin (mTOR) inhibitor everolimus in patients with neuroendocrine tumors (NETs) has been reported but not confirmed in prospective trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17c42386b02cecaf214c73a2b114e0b3
https://europepmc.org/articles/PMC6324631/
https://europepmc.org/articles/PMC6324631/
Background Metastatic castrate-resistant prostate cancer (mCRPC) patients with liver metastases have a poor prognosis. No large studies have investigated the clinical and biochemical parameters associated with liver metastases in this population. Mat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3733012b9dfa819df357fb09f82c1eb1
https://europepmc.org/articles/PMC6058331/
https://europepmc.org/articles/PMC6058331/
Autor:
Chun-Nan Yeh, Tse-Ching Chen, Wen-Liang Fang, Cheng-Tang Chiu, Keng-Hao Liu, Yu-Yin Liu, Chun-Yi Tsai, Ren-Chin Wu, Jun-Te Hsu, Ta-Sen Yeh, Frank Wang
Background The present study assessed the impact of the retrieval of >25 lymph nodes (LNs) on the survival outcome of patients with advanced gastric cancer after curative-intent gastrectomy. Patients and Methods A total of 5,386 patients who had unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e05ed8c25c84b47000024b17253f164
https://europepmc.org/articles/PMC5313276/
https://europepmc.org/articles/PMC5313276/
Autor:
Chia Jui Yen, Manish A. Shah, David S. Shames, Yoon-Koo Kang, Lilian Bu, Jae Yong Cho, Niall C. Tebbutt, Iain Beehuat Tan, Alice Kang
Background The phase II YO28252 study (NCT01590719) examined first-line onartuzumab plus mFOLFOX6 in patients with metastatic, human epidermal growth factor receptor 2-negative adenocarcinoma of the stomach or gastroesophageal junction. MET immunohis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4cb6418ea1d5c9605b58420b560c3f7
https://europepmc.org/articles/PMC5016069/
https://europepmc.org/articles/PMC5016069/
Autor:
Pagona Flevari, Maria N. Dimopoulou, Xanthoula Yiakoumis, Konstas Konstantopoulos, Kyriaki Petevi, Gabriella Gainaru, Maria Dimou, Panayiotis Tsaftaridis, Eleni Plata, Nora-Athina Viniou, Alexandros Kanellopoulos, George Boutsikas, Katerina Koutsi, Loula Papageorgiou, John Meletis, Panayiotis Panayiotidis, Sotirios Sachanas, Pantelis Tsirkinidis, Maria K. Angelopoulou, Eleni Variami, Gerassimos A. Pangalis, Vassilios Telonis, Maria Moschogiannis, Marie-Christine Kyrtsonis, Marina P. Siakantaris, Theodoros P. Vassilakopoulos
Low absolute lymphocyte count (ALC) to absolute monocyte count (AMC) ratio (ALC/AMC) is an independent prognostic factor in Hodgkin lymphoma (HL), but different cutoffs (1.1, 1.5, and 2.9) have been applied. We aimed to validate the prognostic signif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92e9ad3de9471636f4ce7cffc403e52c
https://europepmc.org/articles/PMC4786349/
https://europepmc.org/articles/PMC4786349/
Autor:
Hyeok Shim, Hye Sook Han, Kyu Taek Lee, Sang-Hee Cho, Hyun-Jeong Shim, Seung Taik Kim, Samyoung Kim, Han Jo Kim, Moon Ki Choi, Jun-Eul Hwang, Ki Hyeong Lee, Moo-Rim Park, Suk Young Park, Hwan Jung Yun, Sang Byung Bae, Woo Kyun Bae, Ji Chan Park, Jihyun Kwon
Background. In a previous pilot study, adrenal suppression was found to be common after antiemetic dexamethasone therapy in cancer patients. The objective of this large prospective multicenter study was to confirm the incidence and factors associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24a26d2aa28c054bfc92ddf6c35dfce5
https://europepmc.org/articles/PMC4679085/
https://europepmc.org/articles/PMC4679085/
Autor:
Catherine Tjan, Keith T. Flaherty, James M. Roach, Silva Krause, Eileen M. O'Reilly, Paul J. E. Miller, Darrell Nix, Kenneth H. Yu, Molly Rosano, William Avery, David P. Ryan, Julie Wolf
Publikováno v:
The Oncologist
Lessons LearnedDespite the compelling preclinical rationale of evaluating the genetically engineered heparin derivative, necuparanib, combined with standard therapy in metastatic pancreas adenocarcinoma, the results were ultimately disappointing. Saf
Autor:
Anfeng Si, Feng Shen, Kui Wang, Jun Li, Wan Yee Lau, Zhengqing Lei, Yizhou Wang, Meng-Chao Wu, Dong Wu, Yong Xia, Xuying Wan, Qing Wang, Zhenlin Yan
Background. The effectiveness of adjuvant transarterial chemoembolization (TACE) for intrahepatic cholangiocarcinoma (ICC) after hepatectomy remains unclear. This study was performed to identify ICC patients who would benefit from adjuvant TACE. Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11d1e6020f997bfe45bfd236b188fb1b
https://europepmc.org/articles/PMC4571785/
https://europepmc.org/articles/PMC4571785/
Autor:
Hawk Kim, Dong Wan Kim, Hong Suk Song, Sung Hwa Bae, Yoon Kyung Jeon, Byung Soo Kim, Dae Seog Heo, Tae Min Kim, Joo-Seop Chung, Young Jin Yuh, Myung Soo Hyun, Chul Woo Kim, Sung Hyun Yang, Yoon-Koo Kang, Hyo Jung Kim, Jong Seok Lee
Background. Combination chemotherapy consisting of ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) was active as first-line and second-line treatment for extranodal natural killer/T-cell lymphoma (NTCL). Methods. Forty-four patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f23327949610d273ea069b1337810354
https://europepmc.org/articles/PMC4221378/
https://europepmc.org/articles/PMC4221378/